(continued)
- Onureg (azacitidine)
- Gavreto (pralsetinib)
- Orgovyx (relugolix)
- Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf)
- Inqovi (decitabine/cedazuridine)
- Darzalex Faspro (daratumumab/hyaluronidase-fihj)
- Tabrecta (capmatinib)
- Retevmo (selpercatinib)
- Oriahnn (elagolix/estradiol/norethindrone and elagolix)
- Koselugo (Selumetinib)
- Tukysa (tucatinib)
- Enhertu (fam-trastuzumab deruxtecan-nxki)
- Beovu (Brolucizumab)
- Brukinsa (zanubrutinib)
- Turalio (Pexidartinib)
- Rozlytrek (entrectinib)
- Inrebic (fedratinib)
- Nubeqa (darolutamide)
- Piqray (Alpelisib)
- Mavenclad (cladribine)
- Oxervate (cenegermin-bkbj)
- Vitrakvi (larotrectinib)
- Xospata (Gilteritinib)
- Talzenna (talazoparib)
- Levoleucovorin (Fusilev, Khapzory)
- Libtayo (cemiplimab-rwlc)
- Vizimpro (dacomitinib)
- Braftovi (encorafenib)
- Mektovi (binimetinib)
- Orilissa (elagolix)
- How Does Enhertu Work for Breast Cancer?
- How Pluvicto Fights Prostate Cancer and What to Expect